Publications du LRB

Angiopoietin‑2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID‑19 patients

Place des anticoagulants oraux directs dans la prise en charge de la maladie thromboembolique veineuse associée au cancer en 2020

Is Covid-19 a new Hematologic Disease ?

Stem Cells Therapeutic Applications – Chapter 11 – David M.Smadja

Targeting endothelial thioredoxin‑interacting protein (TXNIP) protects from metabolic disorder‑related impairment of vascular function and post‑ischemic revascularisation

Elastomeric cardiopatch scaffold for myocardial repair and ventricular support

First clinical use of a bioprosthetic total artifi cial heart: report of two cases.

Bioprosthetic Total Artificial Heart Induces a Profile of Acquired Hemocompatibility With Membranes Recellularization.

The Carmat bioprosthetic total artificial heart is associated with early hemostatic recovery and no acquired Von Willebrand Syndrome in Calves.

The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin.

A bioprosthetic total artificial heart for end-stage heart failure : Results from a pilot study.

Hemocompatibility and safety of the Carmat Total Artifical Heart hybrid membrane

Standardization of methods to quantify and culture endothelial colony‐forming cells derived from peripheral blood